NEW YORK, Jan. 13, 2021 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Penumbra, Inc. (NYSE: PEN) resulting from allegations that Penumbra may have issued materially misleading business information to the investing public.

On November 10, 2020, Quintessential Capital Management released research report on the Company entitled "Penumbra and its 'Killer Catheter': A tale of corporate greed and seemingly blatant disregard for patients' lives[.]"

On December 8, 2020, Quintessential Capital Management released a follow-up research report entitled "Is Penumbra's core scientific research authored by a fake person?: The incredible story of Penumbra's Dr. Antik Bose[.]" The follow-up report alleged that some of the Company's scientific research pieces appear to have been incorrectly attributed or even authored by a fake individual. On this news, Penumbra's share price fell $19.95 per share, or almost 9%, to close at $204.07 per share on December 8, 2020.

On December 15, 2020, after the markets closed, Penumbra announced that it was "voluntarily recalling all configurations" of its JET 7 Xtra Flex Reperfusion Catheter "because the catheter may become susceptible to distal tip damage during use."

More on S For Story

• Drone Light Shows Emerge as the New Standard in Live Event Entertainment
• Lore Link is Here to Help Organize Your Game
• Groups Now Included in Basic Authors Training course
• Chappaqua's Annual Townwide Summer Sale – Unbeatable Savings at Your Favorite Local Boutiques!
• History Matters: Book Recommendations for July

Following the recall, Penumbra's shares fell $13.84 per share, or 7.3%, to close at $174.98 on December 16, 2020.

Rosen Law Firm is preparing a securities lawsuit on behalf of Penumbra shareholders. If you purchased securities of Penumbra please visit the firm's website at http://www.rosenlegal.com/cases-register-2003.html to join the securities action. You may also contact Phillip Kim of Rosen Law Firm toll free at 866-767-3653 or via email at [email protected] or [email protected].

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm.

More on S For Story

• Skyline Partners with ZenSpace to Offer Private Meeting Pods for Trade Show Exhibitors
• Powerful Stories and Shared Sisterhood Shine at "An Evening with the Author" Featuring Staci Kirk
• AI Innovation Dual-Strategy Business Model Focused on Real Estate Development for Strategic Expansion: OFA Group, (N A S D A Q: OFAL)
• Construcción del Corredor Norte–Sur (NSC) de Singapur
• New Report: Slip and Fall Accidents Rank as the Leading Cause of Construction Site Fatalities

Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 3 each year since 2013. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm's attorneys are ranked and recognized by numerous independent and respected sources. Rosen Law Firm has secured hundreds of millions of dollars for investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40^th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
[email protected]
[email protected]
[email protected]
www.rosenlegal.com

SOURCE Rosen Law Firm, P.A.

Related Links

www.rosenlegal.com

---

Show All News | Report Violation